2008 Annual Meeting
(68a) Emulsion Function in a Simulated Gastric Environment. A Quantitative Study of Digestion Kinetics and Intestinal Permeability Enhancement
Authors
To gain a greater understanding of the dependence of emulsion function in the gastrointestinal (GI) tract on formulation design, a quantitative study of processes central to emulsion function, digestion and intestinal permeability enhancement, was undertaken. A broad range of formulations was studied: Oils from three different structural classes (long chain triglyceride (Soybean oil), medium chain trigylcerides (Neobee M5), and propylene glycol dicaprylate/dicaprate (Captex 200)) and surfactants varying in hydrophilic-lipophilic balance (HLB) value from 10-15 (Cremophor EL, Tween 80, a mixture of Capmul MCM and Labrasol) were combined at three different ratios. Naproxen was included to test the influence of drug on emulsion properties. The dependence of emulsion formation and emulsion characteristics on physicochemical emulsion formulation properties was investigated. An HLB value of 10 or higher was required for spontaneous emulsification; emulsions formed had particle sizes ranging from 60-500 nm. MTT assay results showed that only oil-surfactant mixtures that did not spontaneously form emulsions were toxic. Changes in transcellular permeability were assessed by measuring drug transport across epithelial layers, and epithelial tight junction integrity was assessed by measuring transepithelial electric resistance. Formulations composed of high levels of high HLB surfactant (Tween 80) significantly reduced epithelial tight junction integrity. Digestion kinetics were studied by monitoring the change in particle size and by quantitative analysis of digestion products by HPLC upon exposure of emulsions to digestive enzymes. Ultimately, the relation of emulsion formulation physical and chemical properties to relative kinetics of processes occurring in the GI tract (permeation enhancement, digestion, drug release) will be utilized to aid in rational design of emulsions and fulfillment of the tremendous potential of this technology for oral bioavailablility enhancement.
References
[1] Neslihan Gursoy, et al. Biomedicine Pharmacotherapy, 58; 173 (2004).
[2] Charman, William N., et al. Journal of Pharmaceutical Sciences,89; 967 (2000).